Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Globus Medical, Inc. Class A Common Stock (NY:GMED)

62.52 +2.02 (+3.34%)
Official Closing Price Updated: 7:00 PM EDT, Aug 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Sherwin-Williams, Sealed Air, Super Micro, Globus Medical, and Haemonetics Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested... 
Via StockStory
Topics ETFs Economy
Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage
Carlsmed secures NTAP reimbursement and FDA support, while BofA projects strong revenue growth and assigns a Buy rating with a $16 target. 
Via Benzinga
Globus Medical Inc - A (NYSE:GMED): A Prime Example of Affordable Growth with Strong Fundamentals
Globus Medical (GMED) exemplifies Affordable Growth investing with strong revenue/earnings growth, reasonable valuation, and solid profitability—ideal for GARP-focused investors. 
Via Chartmill
Earnings Scheduled For August 7, 2025
 
Via Benzinga
How Is The Market Feeling About Globus Medical?
 
Via Benzinga
Price Over Earnings Overview: Globus Medical
 
Via Benzinga
1 Cash-Producing Stock Worth Your Attention and 2 We Find Risky
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
Inspire Medical Systems, UFP Technologies, Globus Medical, Neogen, and Dentsply Sirona Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. 
Via StockStory
Topics Bonds Economy Stocks
GMED Q2 Deep Dive: New CEO, Nevro Integration, and Product Pipeline Propel Growth
Medical device company Globus Medical (NYSE:GMED) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 18.4% year on year to $745.3 million. The company expects the full... 
Via StockStory
Topics Economy
Is the Market Bullish or Bearish on Globus Medical?
 
Via Benzinga
Globus Medical (GMED) Shares Skyrocket, What You Need To Know
Shares of medical device company Globus Medical (NYSE:GMED) jumped 5.1% in the morning session after the company reported strong second-quarter financial results that surpassed Wall Street's... 
Via StockStory
Globus Medical (NYSE:GMED) Exceeds Q2 Expectations
Medical device company Globus Medical (NYSE:GMED) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 18.4% year on year to $745.3 million. The company expects the full year’s revenue... 
Via StockStory
Globus Medical (GMED) Q2 Revenue Up 18%
Via The Motley Fool
Globus Medical Reports Second Quarter 2025 Results
From Globus Medical
Via GlobeNewswire
Globus Medical Inc - A (NYSE:GMED): A Strong Growth Stock with a Promising Technical Setup
Globus Medical (GMED) combines strong fundamentals—32% revenue growth, solid profitability, and zero debt—with a technical setup hinting at a potential breakout. A growth stock worth watching. 
Via Chartmill
Globus Medical (GMED) Q2 Earnings: What To Expect
Medical device company Globus Medical (NYSE:GMED) will be reporting results this Thursday after market hours. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence World Trade
1 Safe-and-Steady Stock Worth Investigating and 2 We Find Risky
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
Topics Supply Chain
Globus Medical Inc - A (NYSE:GMED): A Strong GARP Candidate with Solid Growth and Fair Valuation
Globus Medical (GMED) offers strong growth, solid profitability, and fair valuation, making it an ideal GARP strategy pick for investors seeking balanced returns. 
Via Chartmill
Why Globus Medical (GMED) Shares Are Trading Lower Today
Shares of medical device company Globus Medical (NYSE:GMED) fell 6.6% in the afternoon session after the unexpected resignation of its President and CEO, Daniel Scavilla. 
Via StockStory
Topics Government World Trade
Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results
From Globus Medical
Via GlobeNewswire
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
2 Oversold Stocks Set for a Comeback and 1 to Ignore
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds. 
Via StockStory
4 Analysts Assess Globus Medical: What You Need To Know
 
Via Benzinga
Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue
From Globus Medical
Via GlobeNewswire
GLOBUS MEDICAL INC - A (NYSE:GMED) – A Strong Growth Stock with Technical Breakout Potential
Globus Medical (NYSE:GMED) is a strong growth stock with solid fundamentals and a potential technical breakout, making it a candidate for investors seeking growth opportunities in the healthcare... 
Via Chartmill
GLOBUS MEDICAL INC - A (NYSE:GMED) – A Strong Growth Stock with Reasonable Valuation
Globus Medical (NYSE:GMED) offers strong growth, solid profitability, and reasonable valuation, making it an attractive pick for investors seeking affordable growth in the healthcare sector. 
Via Chartmill
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc.  - GMED
From Pomerantz LLP
Via GlobeNewswire
2 Reasons to Watch GMED and 1 to Stay Cautious
Shareholders of Globus Medical would probably like to forget the past six months even happened. The stock dropped 28.9% and now trades at $58.14. This was partly due to its softer quarterly results and... 
Via StockStory
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc.  - GMED
From Pomerantz LLP
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.